Clinicn Investigator, Full Prf Psych CTNI MGPO, Mass General Research Institute

Professor of Psychiatry Harvard Medical School

Psychiatrist Psychiatry, Massachusetts General Hospital

MD 1998

antidepressive agents; antidepressive agents second-generation; depressive disorder major; fluoxetine; s-adenosylmethionine; serotonin uptake inhibitors; treatment-resistant depression Dr. Papakostas is involved in overseeing numerous studies focusing on the diagnosis, treatment, and management of Major Depressive Disorder that is resistant or refractory to standard therapy. He is also active in educating clinicians locally, regionally, nationally, and internationally on the management of major depressive disorder, as well as in disseminating cutting-edge research in this field of study through numerous manuscripts published in top-notch scientific journals. Dr. Papakostas is also coauthor of the book entitled: "Parmacotherapy for Depression and Treatment-Resistant Depression" which, currently is the most up-to-date and comprehensive source document focusing on the treatment of this medical illness.